Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T15377 |
Ravoxertinib hydrochloride
GDC-0994 (hydrochloride) |
ERK | MAPK |
Ravoxertinib hydrochloride is an orally bioavailable and selective inhibitor for ERK kinase activity (IC50: 6.1 nM and 3.1 nM for ERK1 and ERK2, respectively). | |||
T6511 |
Ravoxertinib
GDC-0994 |
ERK | MAPK |
Ravoxertinib (GDC-0994) 是可口服的ERK 激酶抑制剂,抑制ERK1和ERK2的IC50分别为 6.1 和 3.1 nM。 |